Transcriptomics

Dataset Information

0

Effect of C13 MOK-inhibitor on LPS-induced responses in primary microglial cells

ABSTRACT: To investigate the possible impact of MOK in microglial immune responses, we tested the effect of MOK-inhibition with the chemical compound C13, in LPS-stimulated microglial cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE233719 | GEO | 2023/06/30

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Effect of C13 MOK-inhibitor on LPS-induced responses in primary microglial cells
| PRJNA977653 | ENA
Transcriptomics RNA-seq of LPS-challenged microglial cell treatment with TOP1 inhibitor
2022-04-27 | E-MTAB-10679 | biostudies-arrayexpress
Transcriptomics Effect of MOK in LPS-induced responses in microglial cells
2023-06-30 | GSE234160 | GEO
Transcriptomics LPS and Telmisartan co-treatment of microglial BV2 cells
2018-07-02 | GSE108669 | GEO
Genomics Effect of MOK in LPS-induced responses in microglial cells
| PRJNA980219 | ENA
Transcriptomics LPS, Telmisartan and GW9662 co-treatment of microglial BV2 cells
2018-07-02 | GSE108670 | GEO
Genomics RNA-seq of LPS-challenged microglial cell treatment with TOP1 inhibitor
| PRJEB46100 | ENA
Transcriptomics Transcription profiles of BV2 microglial cell lines- unstimulated or stimulated with LPS or transfected with constitutively active Stat1 and Stat3.
2014-06-19 | E-MEXP-3659 | biostudies-arrayexpress
Genomics LPS, Telmisartan and GW9662 treatment of microglial BV2 cells
| PRJNA428232 | ENA
Genomics LPS and Telmisartan co-treatment of microglial BV2 cells
| PRJNA428238 | ENA